GW Pharmaceuticals announces patent allowance for cannabinoid treatment GW Pharmaceuticals announced that the United States Patent and Trademark Office, USPTO, has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma. Shares of GW Pharmaceuticals are higher by almost 9% to $33.60 in late morning trading.
News For GWPH From The Last 14 Days
Check below for free stories on GWPH the last two weeks.